Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wasson

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Metabolic engineering improves transduction efficiency and downstream vector isolation by altering the lipid composition of extracellular vesicle-enclosed AAVPaula Espinoza, Ming Cheng, Carrie Ng, et al.
Cancers|January 21, 2023
The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and BeyondMeghan E McLean, Maya R MacLean, Hannah F Cahill, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 6, 2022
Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasisMargaret L Dahn, Hayley R Walsh, Cheryl A Dean, et al.
Cancers|June 2, 2021
LncRNA <i>PART1</i> Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast CancerBrianne M Cruickshank, Marie-Claire D Wasson, Justin M Brown, et al.
Oncogene|September 9, 2024
ALDH1A3 is the switch that determines the balance of ALDH<sup>+</sup> and CD24<sup>-</sup>CD44<sup>+</sup> cancer stem cells, EMT-MET, and glucose metabolism in breast cancerWasundara Fernando, Brianne M Cruickshank, Raj Pranap Arun, et al.
Molecular Oncology|September 27, 2023
ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathwayAlamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, et al.
Biomarker Research|October 29, 2025
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.
Iscience|April 17, 2026
LINC01929 mediates breast cancer immunosuppression and is an immunotherapy targetJaganathan Venkatesh, Marie-Claire D Wasson, Raj Pranap Arun, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Metabolic engineering improves transduction efficiency and downstream vector isolation by altering the lipid composition of extracellular vesicle-enclosed AAVPaula Espinoza, Ming Cheng, Carrie Ng, et al.
Cancers|January 21, 2023
The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and BeyondMeghan E McLean, Maya R MacLean, Hannah F Cahill, et al.
Metabolomics : Official Journal of the Metabolomic Society|January 6, 2022
Metabolite profiling reveals a connection between aldehyde dehydrogenase 1A3 and GABA metabolism in breast cancer metastasisMargaret L Dahn, Hayley R Walsh, Cheryl A Dean, et al.
Cancers|June 2, 2021
LncRNA <i>PART1</i> Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast CancerBrianne M Cruickshank, Marie-Claire D Wasson, Justin M Brown, et al.
Oncogene|September 9, 2024
ALDH1A3 is the switch that determines the balance of ALDH<sup>+</sup> and CD24<sup>-</sup>CD44<sup>+</sup> cancer stem cells, EMT-MET, and glucose metabolism in breast cancerWasundara Fernando, Brianne M Cruickshank, Raj Pranap Arun, et al.
Molecular Oncology|September 27, 2023
ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathwayAlamelu G Bharadwaj, Meghan E McLean, Margaret L Dahn, et al.
Biomarker Research|October 29, 2025
THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancerOlivia L Walker, Marie-Claire D Wasson, Vishnupriyan Kumar, et al.
Iscience|April 17, 2026
LINC01929 mediates breast cancer immunosuppression and is an immunotherapy targetJaganathan Venkatesh, Marie-Claire D Wasson, Raj Pranap Arun, et al.
Pageof 4